Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 24, 2022

Effects of Mineralocorticoid Receptor Antagonists on CV Outcomes in Patients With ESRD and HF

European Journal of Heart Failure


Additional Info

European Journal of Heart Failure
The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end-stage renal disease and heart failure
Eur. J. Heart Fail 2022 Nov 20;[EPub Ahead of Print], DS Lin, FJ Lin, YS Lin, JK Lee, YH Lin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading